3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Lymphoma, AIDS-Related
1
HIV Infections
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Cyclophosphamide
46
fludarabine phosphate
24
Busulfan
22
Peripheral Blood Stem Cell Transplantation
20
Radiotherapy
19
Filgrastim
19
Mycophenolic Acid
18
Antilymphocyte Serum
18
Cyclosporine
17
Whole-Body Irradiation
16
Rituximab
16
Etoposide
16
Methotrexate
15
Melphalan
15
Methylprednisolone
14
Tacrolimus
12
Cytarabine
12
Vincristine
10
Prednisone
10
Doxorubicin
10
Cord Blood Stem Cell Transplantation
10
Thiotepa
6
Granulocyte Colony-Stimulating Factor
6
Leucovorin
5
sargramostim
4
fludarabine
4
Daunorubicin
4
glofitamab
3
Sirolimus
3
Methylprednisolone Hemisuccinate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Dendritic Cell Sarcoma, Interdigitating
×
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
×
Clear all
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled